NCT00949546View on ClinicalTrials.gov

Treatment of Hidradenitis Suppurativa Using Etanercept

CompletedOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Hidradenitis Suppurativa

Interventions

DRUG

etanercept

etanercept 50 mg sc twice weekly

Trial Locations (1)

17033

Penn State Milton S. Hershey Medical Center, Hershey

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

lead

Penn State University

OTHER